Skip to main content
Top
Published in: Hormones 3/2023

Open Access 28-06-2023 | Hypoparathyroidism | Original Article

Hypoparathyroidism – management, information needs, and impact on daily living from the patients’ perspective: results from a population-based survey

Authors: Matthias Büttner, Dieter Krogh, Dagmar Führer, Carmina Teresa Fuß, Holger Sven Willenberg, Markus Luster, Susanne Singer, Heide Siggelkow

Published in: Hormones | Issue 3/2023

Login to get access

Abstract

Purpose

Hypoparathyriodism (hypoPT) is a rare endocrine disorder. It is not known how hypoPT is managed in Germany or whether patients have unmet information needs or impairments in their daily living.

Methods

HypoPT patients at a minimum of 6 months’ post-diagnosis were invited to participate in an online survey through their treating physician or through patient organizations. An extensive questionnaire, which was developed and pilot-tested with hypoPT patients, was administered.

Results

A total of 264 patients with a mean age of 54.5 years (SD: 13.3), 85.2% female and 92% with postsurgical hypoPT, participated in the study. In total, 74% of the patients reported regular monitoring of serum calcium at least every 6 months, with lower control frequencies for phosphate (47%), magnesium (36%), creatinine (54%), and parathyroid hormone (50%), and 24-h urine calcium excretion (36%) on a yearly basis. Information on symptoms of hypo- and hypercalcemia was available in 72 and 45% of the patients. Information needs were related to the disease and its treatment as well as to nutrition, physical activities/sports, and support opportunities. Statistically significant differences for all information needs in association with symptom burden were observed. Hospitalization for hypocalcemia was reported by 32%, nutritional impairments (38%) or impact on work ability (52%) was available among patients with hypoPT.

Conclusion

HypoPT patients experience impairments in daily living and report unmet information needs. Patient and physician education regarding hypoPT is one of the key concepts for improving the management of patients with hypoPT.
Literature
2.
go back to reference Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W et al (2015) European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 173(2):G1-20PubMedCrossRef Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W et al (2015) European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 173(2):G1-20PubMedCrossRef
3.
go back to reference Astor MC, Lovas K, Debowska A, Eriksen EF, Evang JA, Fossum C et al (2016) Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway. J Clin Endocrinol Metab 101(8):3045–3053PubMedPubMedCentralCrossRef Astor MC, Lovas K, Debowska A, Eriksen EF, Evang JA, Fossum C et al (2016) Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway. J Clin Endocrinol Metab 101(8):3045–3053PubMedPubMedCentralCrossRef
4.
go back to reference Powers J, Joy K, Ruscio A, Lagast H (2013) Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res 28(12):2570–2576PubMedCrossRef Powers J, Joy K, Ruscio A, Lagast H (2013) Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res 28(12):2570–2576PubMedCrossRef
5.
go back to reference Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28(11):2277–2285PubMedCrossRef Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28(11):2277–2285PubMedCrossRef
6.
go back to reference Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study. J Bone Miner Res 30(9):1738–1744PubMedCrossRef Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study. J Bone Miner Res 30(9):1738–1744PubMedCrossRef
7.
go back to reference Bilezikian JP, Brandi ML, Cusano NE, Mannstadt M, Rejnmark L, Rizzoli R et al (2016) Management of Hypoparathyroidism: Present and Future. J Clin Endocrinol Metab 101(6):2313–2324PubMedPubMedCentralCrossRef Bilezikian JP, Brandi ML, Cusano NE, Mannstadt M, Rejnmark L, Rizzoli R et al (2016) Management of Hypoparathyroidism: Present and Future. J Clin Endocrinol Metab 101(6):2313–2324PubMedPubMedCentralCrossRef
8.
go back to reference Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L et al (2021) European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders. Eur J Endocrinol 186(2):R33–R63PubMedCentralCrossRef Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L et al (2021) European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders. Eur J Endocrinol 186(2):R33–R63PubMedCentralCrossRef
9.
go back to reference Bollerslev J, Schalin-Jantti C, Rejnmark L, Siggelkow H, Morreau H, Thakker R et al (2019) MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur J Endocrinol 181(3):P1–P19PubMedPubMedCentralCrossRef Bollerslev J, Schalin-Jantti C, Rejnmark L, Siggelkow H, Morreau H, Thakker R et al (2019) MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur J Endocrinol 181(3):P1–P19PubMedPubMedCentralCrossRef
10.
go back to reference Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV et al (2016) Management of Hypoparathyroidism: Summary Statement and Guidelines. J Clin Endocrinol Metab 101(6):2273–2283PubMedCrossRef Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV et al (2016) Management of Hypoparathyroidism: Summary Statement and Guidelines. J Clin Endocrinol Metab 101(6):2273–2283PubMedCrossRef
11.
go back to reference Khan AA, Koch CA, Van Uum S, Baillargeon JP, Bollerslev J, Brandi ML et al (2019) Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol 180(3):P1–P22PubMedCrossRef Khan AA, Koch CA, Van Uum S, Baillargeon JP, Bollerslev J, Brandi ML et al (2019) Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol 180(3):P1–P22PubMedCrossRef
12.
go back to reference Orloff LA, Wiseman SM, Bernet VJ, Fahey TJ 3rd, Shaha AR, Shindo ML et al (2018) American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults. Thyroid 28(7):830–841PubMedCrossRef Orloff LA, Wiseman SM, Bernet VJ, Fahey TJ 3rd, Shaha AR, Shindo ML et al (2018) American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults. Thyroid 28(7):830–841PubMedCrossRef
13.
go back to reference Allemeyer EH, Kossow MS, Riemann B, Hoffmann MW (2019) Outpatient quality of care for permanent postoperative hypoparathyroidism. Dtsch Med Wochenschr 144(21):e130–e137PubMed Allemeyer EH, Kossow MS, Riemann B, Hoffmann MW (2019) Outpatient quality of care for permanent postoperative hypoparathyroidism. Dtsch Med Wochenschr 144(21):e130–e137PubMed
14.
go back to reference Astor MC, Zhu W, Bjornsdottir S, Bollerslev J, Kampe O, Husebye ES (2019) Is there a need for an emergency card in hypoparathyroidism? J Intern Med 285(4):429–435PubMedCrossRef Astor MC, Zhu W, Bjornsdottir S, Bollerslev J, Kampe O, Husebye ES (2019) Is there a need for an emergency card in hypoparathyroidism? J Intern Med 285(4):429–435PubMedCrossRef
15.
go back to reference Hadker N, Egan J, Sanders J, Lagast H, Clarke BL (2014) Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study. Endocr Pract 20(7):671–679PubMedCrossRef Hadker N, Egan J, Sanders J, Lagast H, Clarke BL (2014) Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study. Endocr Pract 20(7):671–679PubMedCrossRef
16.
go back to reference Hamdy NAT, Decallonne B, Evenepoel P, Gruson D, van Vlokhoven-Verhaegh L (2021) Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands survey. J Endocrinol Invest 44(7):1437–1446PubMedCrossRef Hamdy NAT, Decallonne B, Evenepoel P, Gruson D, van Vlokhoven-Verhaegh L (2021) Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands survey. J Endocrinol Invest 44(7):1437–1446PubMedCrossRef
17.
go back to reference Meola A, Vignali E, Matrone A, Cetani F, Marcocci C (2018) Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism. J Endocrinol Invest 41(10):1221–1226PubMedCrossRef Meola A, Vignali E, Matrone A, Cetani F, Marcocci C (2018) Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism. J Endocrinol Invest 41(10):1221–1226PubMedCrossRef
18.
go back to reference Buttner M, Musholt TJ, Singer S (2017) Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine 58(1):14–20PubMedCrossRef Buttner M, Musholt TJ, Singer S (2017) Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine 58(1):14–20PubMedCrossRef
19.
go back to reference Anaforoglu I, Sancak S, Akbas EM, Oruk GG, Canat M, Tezcan KA et al (2021) Effects of Treatment Adherence on Quality of Life in Hypoparathyroid Patients. Exp Clin Endocrinol Diabetes 129(12):918–925PubMedCrossRef Anaforoglu I, Sancak S, Akbas EM, Oruk GG, Canat M, Tezcan KA et al (2021) Effects of Treatment Adherence on Quality of Life in Hypoparathyroid Patients. Exp Clin Endocrinol Diabetes 129(12):918–925PubMedCrossRef
20.
go back to reference Chen K, Krasner A, Li N, Xiang CQ, Totev T, Xie J (2019) Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart review. J Med Econ 22(11):1141–1152PubMedCrossRef Chen K, Krasner A, Li N, Xiang CQ, Totev T, Xie J (2019) Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart review. J Med Econ 22(11):1141–1152PubMedCrossRef
21.
go back to reference Darba J, Marsa A (2020) Epidemiology and management of parathyroid gland disorders in Spain over 15 years: A retrospective multicentre analysis. PLoS ONE 15(3):e0230130PubMedPubMedCentralCrossRef Darba J, Marsa A (2020) Epidemiology and management of parathyroid gland disorders in Spain over 15 years: A retrospective multicentre analysis. PLoS ONE 15(3):e0230130PubMedPubMedCentralCrossRef
22.
go back to reference David K, Moyson C, Vanderschueren D, Decallonne B (2019) Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study. Eur J Endocrinol 180(1):71–78PubMedCrossRef David K, Moyson C, Vanderschueren D, Decallonne B (2019) Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study. Eur J Endocrinol 180(1):71–78PubMedCrossRef
23.
go back to reference Khan AA, AbuAlrob H, Punthakee Z, Shrayyef M, Werfalli RE, Kassem HA et al (2021) Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada. Endocrine 72(2):553–561PubMedCrossRef Khan AA, AbuAlrob H, Punthakee Z, Shrayyef M, Werfalli RE, Kassem HA et al (2021) Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada. Endocrine 72(2):553–561PubMedCrossRef
24.
go back to reference Zanchetta MB, Robbiani D, Oliveri B, Giacoia E, Frigeri A, Kallsbrum S et al (2021) Hipopara-Red, Real Life Experience in 322 Patients With Hypoparathyroidism. J Endocr Soc. 5(2):bvaa81CrossRef Zanchetta MB, Robbiani D, Oliveri B, Giacoia E, Frigeri A, Kallsbrum S et al (2021) Hipopara-Red, Real Life Experience in 322 Patients With Hypoparathyroidism. J Endocr Soc. 5(2):bvaa81CrossRef
25.
go back to reference Siggelkow H, Clarke BL, Germak J, Marelli C, Chen K, Dahl-Hansen H et al (2020) Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey. Clin Endocrinol (Oxf) 92(2):159–68PubMedCrossRef Siggelkow H, Clarke BL, Germak J, Marelli C, Chen K, Dahl-Hansen H et al (2020) Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey. Clin Endocrinol (Oxf) 92(2):159–68PubMedCrossRef
26.
go back to reference Buttner M, Krogh D, Siggelkow H, Singer S (2022) What are predictors of impaired quality of life in patients with hypoparathyroidism? Clin Endocrinol (Oxf)97(3):268-275 Buttner M, Krogh D, Siggelkow H, Singer S (2022) What are predictors of impaired quality of life in patients with hypoparathyroidism? Clin Endocrinol (Oxf)97(3):268-275
27.
go back to reference Wilde D, Wilken L, Stamm B, Heppner C, Leha A, Blaschke M et al (2020) Quantification of Symptom Load by a Disease-Specific Questionnaire HPQ 28 and Analysis of Associated Biochemical Parameters in Patients With Postsurgical Hypoparathyroidism. JBMR Plus 4(7):e10368PubMedPubMedCentralCrossRef Wilde D, Wilken L, Stamm B, Heppner C, Leha A, Blaschke M et al (2020) Quantification of Symptom Load by a Disease-Specific Questionnaire HPQ 28 and Analysis of Associated Biochemical Parameters in Patients With Postsurgical Hypoparathyroidism. JBMR Plus 4(7):e10368PubMedPubMedCentralCrossRef
28.
go back to reference Marcucci G, Cianferotti L, Parri S, Altieri P, Arvat E, Benvenga S et al (2018) HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy. Calcif Tissue Int 103(2):151–163PubMedCrossRef Marcucci G, Cianferotti L, Parri S, Altieri P, Arvat E, Benvenga S et al (2018) HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy. Calcif Tissue Int 103(2):151–163PubMedCrossRef
29.
go back to reference Gronskaia S, Melnichenko G, Rozhinskaya L, Grebennikova T, Mamedova E, Pigarova E et al (2020) A registry for patients with chronic hypoparathyroidism in Russian adults. Endocr Connect 9(7):627–636PubMedPubMedCentralCrossRef Gronskaia S, Melnichenko G, Rozhinskaya L, Grebennikova T, Mamedova E, Pigarova E et al (2020) A registry for patients with chronic hypoparathyroidism in Russian adults. Endocr Connect 9(7):627–636PubMedPubMedCentralCrossRef
30.
go back to reference Leidig-Bruckner G, Bruckner T, Raue F, Frank-Raue K (2016) Long-Term Follow-Up and Treatment of Postoperative Permanent Hypoparathyroidism in Patients with Medullary Thyroid Carcinoma: Differences in Complete and Partial Disease. Horm Metab Res 48(12):806–813PubMedCrossRef Leidig-Bruckner G, Bruckner T, Raue F, Frank-Raue K (2016) Long-Term Follow-Up and Treatment of Postoperative Permanent Hypoparathyroidism in Patients with Medullary Thyroid Carcinoma: Differences in Complete and Partial Disease. Horm Metab Res 48(12):806–813PubMedCrossRef
31.
go back to reference Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB et al (2012) Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 97(12):4507–4514PubMedPubMedCentralCrossRef Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB et al (2012) Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 97(12):4507–4514PubMedPubMedCentralCrossRef
33.
go back to reference Deutsche Gesellschaft für Kinderendokrinologie und –diabetologie (DGKED) e.V. (2016) S1-Leitlinie – Hypoparathyreoidismus und Pseudohypoparathyreoidismus Deutsche Gesellschaft für Kinderendokrinologie und –diabetologie (DGKED) e.V. (2016) S1-Leitlinie – Hypoparathyreoidismus und Pseudohypoparathyreoidismus
34.
go back to reference Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie (2021) Offizielle Empfehlung der Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie zur Behandlung des postoperativen Hypoparathyreoidismus Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie (2021) Offizielle Empfehlung der Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie zur Behandlung des postoperativen Hypoparathyreoidismus
35.
go back to reference Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Potts JJ, Mannstadt M et al (2022) The Second International Workshop on the Evaluation and Management of Hypoparathyroidism. J Bone Miner Res 37(12):2566–2567PubMedCrossRef Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Potts JJ, Mannstadt M et al (2022) The Second International Workshop on the Evaluation and Management of Hypoparathyroidism. J Bone Miner Res 37(12):2566–2567PubMedCrossRef
36.
go back to reference Diez JJ, Anda E, Sastre J, Corral BP, Alvarez-Escola C, Manjon L et al (2021) Late Recovery of Parathyroid Function After Total Thyroidectomy: A Case-Control Study. Horm Metab Res 53(10):654–661PubMedCrossRef Diez JJ, Anda E, Sastre J, Corral BP, Alvarez-Escola C, Manjon L et al (2021) Late Recovery of Parathyroid Function After Total Thyroidectomy: A Case-Control Study. Horm Metab Res 53(10):654–661PubMedCrossRef
37.
go back to reference Quinkler M, Dahlqvist P, Husebye ES, Kampe O (2015) A European Emergency Card for adrenal insufficiency can save lives. Eur J Intern Med 26(1):75–76PubMedCrossRef Quinkler M, Dahlqvist P, Husebye ES, Kampe O (2015) A European Emergency Card for adrenal insufficiency can save lives. Eur J Intern Med 26(1):75–76PubMedCrossRef
38.
go back to reference Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D et al (2015) High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 100(2):407–416PubMedCrossRef Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D et al (2015) High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 100(2):407–416PubMedCrossRef
39.
go back to reference Notter A, Jenni S, Christ E (2018) Evaluation of the frequency of adrenal crises and preventive measures in patients with primary and secondary adrenal insufficiency in Switzerland. Swiss Med Wkly 148:w14586PubMed Notter A, Jenni S, Christ E (2018) Evaluation of the frequency of adrenal crises and preventive measures in patients with primary and secondary adrenal insufficiency in Switzerland. Swiss Med Wkly 148:w14586PubMed
40.
go back to reference Musholt TJ, Bockisch A, Clerici T, Dotzenrath C, Dralle H, Goretzki PE et al (2018) Update of the S2k guidelines : Surgical treatment of benign thyroid diseases. Chirurg 89(9):699–709PubMedCrossRef Musholt TJ, Bockisch A, Clerici T, Dotzenrath C, Dralle H, Goretzki PE et al (2018) Update of the S2k guidelines : Surgical treatment of benign thyroid diseases. Chirurg 89(9):699–709PubMedCrossRef
41.
go back to reference Cipriani C, Pepe J, Biamonte F, Manai R, Biondi P, Nieddu L et al (2017) The Epidemiology of Hypoparathyroidism in Italy: An 8-Year Register-Based Study. Calcif Tissue Int 100(3):278–285PubMedCrossRef Cipriani C, Pepe J, Biamonte F, Manai R, Biondi P, Nieddu L et al (2017) The Epidemiology of Hypoparathyroidism in Italy: An 8-Year Register-Based Study. Calcif Tissue Int 100(3):278–285PubMedCrossRef
42.
go back to reference Cho NL, Moalem J, Chen L, Lubitz CC, Moore FD Jr, Ruan DT (2014) Surgeons and patients disagree on the potential consequences from hypoparathyroidism. Endocr Pract 20(5):427–446PubMedCrossRef Cho NL, Moalem J, Chen L, Lubitz CC, Moore FD Jr, Ruan DT (2014) Surgeons and patients disagree on the potential consequences from hypoparathyroidism. Endocr Pract 20(5):427–446PubMedCrossRef
43.
go back to reference Arneiro AJ, Duarte BCC, Kulchetscki RM, Cury VBS, Lopes MP, Kliemann BS et al (2018) Self-report of psychological symptoms in hypoparathyroidism patients on conventional therapy. Arch Endocrinol Metab 62(3):319–324PubMedPubMedCentral Arneiro AJ, Duarte BCC, Kulchetscki RM, Cury VBS, Lopes MP, Kliemann BS et al (2018) Self-report of psychological symptoms in hypoparathyroidism patients on conventional therapy. Arch Endocrinol Metab 62(3):319–324PubMedPubMedCentral
44.
go back to reference Kim SH, Rhee Y, Kim YM, Won YJ, Noh J, Moon H et al (2020) Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study. PLoS ONE 15(5):e0232842PubMedPubMedCentralCrossRef Kim SH, Rhee Y, Kim YM, Won YJ, Noh J, Moon H et al (2020) Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study. PLoS ONE 15(5):e0232842PubMedPubMedCentralCrossRef
45.
go back to reference Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2014) Postsurgical hypoparathyroidism–risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res 29(11):2504–2510PubMedCrossRef Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2014) Postsurgical hypoparathyroidism–risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res 29(11):2504–2510PubMedCrossRef
46.
go back to reference Riedl D, Gastl R, Gamper E, Arnold CR, Dejaco D, Schoellmann F et al (2018) Cancer patients’ wish for psychological support during outpatient radiation therapy : Findings from a psychooncological monitoring program in clinical routine. Strahlenther Onkol 194(7):655–663PubMedPubMedCentralCrossRef Riedl D, Gastl R, Gamper E, Arnold CR, Dejaco D, Schoellmann F et al (2018) Cancer patients’ wish for psychological support during outpatient radiation therapy : Findings from a psychooncological monitoring program in clinical routine. Strahlenther Onkol 194(7):655–663PubMedPubMedCentralCrossRef
47.
48.
go back to reference Buttner M, Locati LD, Pinto M, Araujo C, Tomaszewska IM, Kiyota N, et al. (2020) Quality of life in patients with hypoparathyroidism after treatment for Thyroid Cancer. J Clin Endocrinol Metab 105(12)):dgaa597 Buttner M, Locati LD, Pinto M, Araujo C, Tomaszewska IM, Kiyota N, et al. (2020) Quality of life in patients with hypoparathyroidism after treatment for Thyroid Cancer. J Clin Endocrinol Metab 105(12)):dgaa597
49.
go back to reference Buttner M, Rimmele H, Bartes B, Singer S, Luster M (2021) Management of thyroid cancer: results from a German and French patient survey. Hormones (Athens) 20(2):323–32PubMedCrossRef Buttner M, Rimmele H, Bartes B, Singer S, Luster M (2021) Management of thyroid cancer: results from a German and French patient survey. Hormones (Athens) 20(2):323–32PubMedCrossRef
Metadata
Title
Hypoparathyroidism – management, information needs, and impact on daily living from the patients’ perspective: results from a population-based survey
Authors
Matthias Büttner
Dieter Krogh
Dagmar Führer
Carmina Teresa Fuß
Holger Sven Willenberg
Markus Luster
Susanne Singer
Heide Siggelkow
Publication date
28-06-2023
Publisher
Springer International Publishing
Published in
Hormones / Issue 3/2023
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.1007/s42000-023-00459-1

Other articles of this Issue 3/2023

Hormones 3/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.